-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOHAVEN - FDA ACCEPTS BIOHAVEN NDA RESUBMISSION FOR VYGLXIA (TRORILUZOLE) IN SCA - SEC FILING

Reuters·10/22/2026 11:05:11

Please log in to view news